Aug 13, 2020
PIQRAY® is approved and now available in Canada as the first and only treatment specifically for patients with a PIK3CA mutation in HR-positive, HER2-negative advanced breast cancer
Jun 22, 2020
Aethlon Medical Presents Hemopurifier® Data at the American Association for Cancer Research 2020 Annual Meeting
Jun 18, 2020
$603.8 Million Worldwide Breast Reconstruction Industry to 2025 - Featuring Allergan, Sientra & Sebbin Among Others
Jun 16, 2020
Verzenio® (abemaciclib) Significantly Reduced the Risk of Cancer Returning in People with High Risk HR+, HER2- Early Breast Cancer
Jun 13, 2020
Athenex Oncology launches Facing MBC Together campaign to address isolation for people living with metastatic breast cancer
Jun 09, 2020
AmoMama Media Limited Announces the #WomenWithWill Project
Jun 09, 2020
Volpara Solutions Helps Customers Resume Breast Screening Operations Amid COVID-19
Jun 04, 2020
Women's Imaging Associates implements ScreenPoint Medical's Transpara® to bring cutting edge 2D and 3D breast AI to benefit the women of Alabama
Jun 04, 2020
Oncolytics Biotech® Provides Recap of Key Opinion Leader Call Highlighting the Induction of Rapid and Persistent Immune Responses With Systemic Pelareorep Treatment
Jun 04, 2020
Cancer Diagnostics Global Market Estimated to Reach $10,627.4 Million by 2026
Jun 03, 2020
QCDx Announces Clinical Study for the Determination of Clinical Utility of the QCDx-br(TM) Liquid Biopsy System to Optimize Treatment Options for Breast Cancer
Jun 03, 2020
Global Breast Cancer Screening Market Outlook, 2020-2026: A $51.8 Billion Opportunity Assessment
May 30, 2020
Chrissy Teigen's Latest Procedures Highlight the Many Reasons Why Patients Choose to Have Plastic Surgery, says Beverly Hills Physicians
May 29, 2020
Exact Sciences Showcases Continued Progress in Cancer Diagnostics at ASCO 2020
May 29, 2020
Agendia Announces Data Presented at ASCO 2020 Demonstrating Importance of Further Classification of Breast Cancers to Enable Precise Prognosis and Treatment
May 27, 2020
Novartis Kisqali® shows overall survival benefit in HR+/HER2- advanced breast cancer with consistent findings in patients with more aggressive disease
May 27, 2020
Pregnancy reprograms breast cells, reducing cancer risk
May 26, 2020
Oncolytics Biotech® Presents Clinical Data Supporting a Predictive Biomarker of Pelareorep Response in Breast Cancer at the ESMO Breast Cancer Virtual Meeting
May 21, 2020
ECOG-ACRIN Provides Syndax Pharmaceuticals With Results of Phase 3 E2112 Trial of Entinostat Plus Exemestane in Patients with HR+, HER2- Breast Cancer
May 20, 2020
Dr. Susan Love Foundation for Breast Cancer Research Rebrands the Army of Women as Love Research Army